NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis $3.35 +0.01 (+0.30%) As of 08/21/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About SeaStar Medical Stock (NASDAQ:ICU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SeaStar Medical alerts:Sign Up Key Stats Today's Range$3.27▼$3.5050-Day Range$2.98▼$5.0852-Week Range$2.07▼$12.50Volume68,738 shsAverage Volume75,177 shsMarket Capitalization$14.76 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies. The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets. Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.AI Generated. May Contain Errors. Read More SeaStar Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreICU MarketRank™: SeaStar Medical scored higher than 67% of companies evaluated by MarketBeat, and ranked 260th out of 914 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingSeaStar Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialSeaStar Medical has a consensus price target of $8.00, representing about 138.8% upside from its current price of $3.35.Amount of Analyst CoverageSeaStar Medical has only been the subject of 1 research reports in the past 90 days.Read more about SeaStar Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SeaStar Medical are expected to grow in the coming year, from ($3.66) to ($2.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SeaStar Medical is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SeaStar Medical is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeaStar Medical has a P/B Ratio of 3.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.30% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 1.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently decreased by 34.37%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSeaStar Medical does not currently pay a dividend.Dividend GrowthSeaStar Medical does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.05 News SentimentSeaStar Medical has a news sentiment score of -0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for SeaStar Medical this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. Company Ownership2.9 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $2,452.00 in company stock, which represents 0.0166% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,452.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.70% of the stock of SeaStar Medical is held by insiders.Percentage Held by Institutions1.69% of the stock of SeaStar Medical is held by institutions.Read more about SeaStar Medical's insider trading history. Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICU Stock News HeadlinesZacks Research Expects Weaker Earnings for SeaStar MedicalAugust 22 at 2:01 AM | americanbankingnews.comICU: Continued Revenue Growth for QUELIMMUNE®August 17, 2026 | finance.yahoo.comA Dark Day Is Coming to AmericaKeith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift in the AI market is approaching, and time is short to prepare. Kaplan points to August 31st as a key turning point for AI investing. He argues the next phase will separate winners from losers, and reveals what he's watching instead of big names like Nvidia.August 22 at 1:00 AM | TradeSmith (Ad)SeaStar Medical (NASDAQ:ICU) Upgraded at Wall Street ZenAugust 15, 2026 | americanbankingnews.comSeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business UpdatesAugust 13, 2026 | markets.businessinsider.comSeastar medical targets NEUTRALIZE-AKI enrollment completion around year-end or Q1 2027 as QUELIMMUNE adoption reaches 20 hospitalsAugust 12, 2026 | seekingalpha.comSeaStar Medical (ICU) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comSeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | seekingalpha.comSee More Headlines ICU Stock Analysis - Frequently Asked Questions How have ICU shares performed this year? SeaStar Medical's stock was trading at $2.40 at the start of the year. Since then, ICU stock has increased by 39.6% and is now trading at $3.35. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Corporation (NASDAQ:ICU) announced its quarterly earnings data on Wednesday, August, 12th. The company reported ($0.91) EPS for the quarter, topping the consensus estimate of ($0.97) by $0.06. The business earned $0.62 million during the quarter, compared to the consensus estimate of $0.49 million. SeaStar Medical had a negative trailing twelve-month return on equity of 162.75% and a negative net margin of 795.51%. Read the conference call transcript. When did SeaStar Medical's stock split? SeaStar Medical's stock reverse split on Monday, January 5th 2026.The 1-10 reverse split was announced on Tuesday, December 23rd 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SeaStar Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V). Company Calendar Last Earnings8/12/2026Today8/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (9m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 ICU's financial health is in the Yellow zone, according to TradeSmith. ICU has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ICU CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees2Year FoundedN/APrice Target and Rating Average Price Target for SeaStar Medical$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+138.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($3.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.15 million Net Margins-795.51% Pretax Margin-795.33% Return on Equity-162.75% Return on Assets-109.89% Debt Debt-to-Equity RatioN/A Current Ratio1.89 Quick Ratio1.87 Sales & Book Value Annual Sales$1.71 million Price / Sales8.62 Cash FlowN/A Price / Cash FlowN/A Book Value$0.97 per share Price / Book3.45Miscellaneous Outstanding Shares4,407,000Free Float4,376,000Market Cap$14.76 million OptionableNot Optionable Beta-1.05 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:ICU) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share SeaStar Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
